TP53 status and impact on AML prognosis within the ELN 2022 risk classification

Shaun Fleming1,2, Xavier Cheng-Hong Tsai3, Rhiannon Morris4

  • 1Australian Centre for Blood Diseases, Monash University, Melbourne, Australia.

Blood
|August 30, 2023
PubMed